XETR
DRW3
Market cap1.74bUSD
Jul 10, Last price
83.80EUR
1D
3.20%
1Q
-11.32%
Jan 2017
4.49%
Name
Draegerwerk AG & Co KGaA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Drägerwerk AG & Co. KGaA, a German company established in 1889 and headquartered in Lübeck, operates as a prominent global provider of medical and safety technology. Its business activities extend across Europe, the Americas, Africa, Asia, and Australia. In the medical domain, Dräger specializes in developing, producing, and marketing comprehensive systems, devices, and support services designed for acute point-of-care settings. This encompasses solutions for emergency departments, surgical procedures (perioperative care), intensive care units, and neonatal care. The company's medical portfolio includes anesthesia machines, ventilators, equipment for thermoregulation, various consumables and accessories, medical supply units, lighting, patient monitoring systems, and specialized software applications. For the safety sector, Dräger delivers products, integrated solutions, and services focused on personal protection, sophisticated gas detection technologies, and overall hazard management. Its clientele spans industrial and mining enterprises, as well as public service organizations like fire departments, police forces, and disaster response agencies. Key safety offerings comprise both fixed and portable gas detection systems, personal protective equipment, and devices for alcohol and drug testing. Additionally, Drägerwerk provides extensive training programs and professional services, notably operating specialized fire training facilities for firefighters.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||